mortality/aging
|
• when treated with tamoxifen at 2 months of age, mice begin to die at 56 days after the first tamoxifen injection, and none survive past 104 days
|
cellular
|
• F-actin accumulations are observed within myofibrils at 1 month after the first tamoxifen injection
|
cardiovascular system
|
• F-actin accumulations are observed within myofibrils at 1 month after the first tamoxifen injection
|
|
• cardiomyocyte size is increased at 1 month after the first tamoxifen injection
|
|
|
• in male mice, the heart weight/body weight ratio begins to increase at 1 month after the first tamoxifen injection
• however, no significant changes are observed in tamoxifen-treated female mice
|
|
• tamoxifen-treated mice exhibit a milder heart hypertrophy relative to that observed in mice that are homozygous for Wdr1tm1.1Zzy and hemizygous for Tg(Myhc-cre)1Xya
|
muscle
|
• F-actin accumulations are observed within myofibrils at 1 month after the first tamoxifen injection
|
|
• cardiomyocyte size is increased at 1 month after the first tamoxifen injection
|
growth/size/body
|
|
• in male mice, the heart weight/body weight ratio begins to increase at 1 month after the first tamoxifen injection
• however, no significant changes are observed in tamoxifen-treated female mice
|
|
• tamoxifen-treated mice exhibit a milder heart hypertrophy relative to that observed in mice that are homozygous for Wdr1tm1.1Zzy and hemizygous for Tg(Myhc-cre)1Xya
|


Analysis Tools